Combivir

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2016
024619982016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND MERIT was a randomized trial comparing maraviroc (MVC) + Combivir versus efavirenz (EFV) + Combivir in drug-naive… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
BACKGROUND In the Treatment Options Preservation Study (TOPS) trial, 4 or 7 days of Combivir (CBV; zidovudine/lamivudine) with… (More)
  • table 1
  • figure 1
  • figure 1
  • figure 2
Is this relevant?
2011
2011
Adherence may be facilitated by reducing perceptual and practical barriers to antiretroviral therapy (ART). Practical barriers… (More)
Is this relevant?
2009
2009
BACKGROUND Single-dose nevirapine (sdNVP)-which prevents mother-to-child transmission of HIV-selects non-nucleoside reverse… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Table of contents 1.0 Introduction 2.0 Methodology 2.1 Basing recommendations on evidence 2.2 Implications for research 2.3 Use… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2007
2007
Combivir is a fixed dose combination tablet of two antiretroviral drugs; zidovudine and lamivudine, used in the treatment of HIV… (More)
Is this relevant?
2006
2006
OBJECTIVES To compare the lipid and metabolic effects, efficacy, and safety of twice-daily regimens of Trizivir (abacavir 300 mg… (More)
Is this relevant?
2003
2003
OBJECTIVE HIV-1 protease inhibitors (versus no protease inhibitors) and stavudine (versus zidovudine) are independently… (More)
Is this relevant?
2002
2002
The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are commonly used in combination antiretroviral therapy and are… (More)
Is this relevant?
2002
2002
BACKGROUND Non-nucleoside reverse transcriptase inhibitor-containing regimens may be a valid alternative to protease inhibitor… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
  • table 3
Is this relevant?